Variant report
Variant | esv3339650 |
---|---|
Chromosome Location | chr8:103062476-103063724 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:103062774..103065761-chr8:103066216..103068204,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535308764 | chr8:103062482-103062483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs56369037 | chr8:103062508-103062509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557281316 | chr8:103062538-103062539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575941739 | chr8:103062602-103062603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375681063 | chr8:103062611-103062612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190674485 | chr8:103062647-103062648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1314532 | chr8:103062698-103062699 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs541555843 | chr8:103062718-103062719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558829771 | chr8:103062811-103062812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7008610 | chr8:103062867-103062868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62522999 | chr8:103062890-103062891 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs545429240 | chr8:103062900-103062901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117299805 | chr8:103063013-103063014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531256062 | chr8:103063020-103063021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs118111815 | chr8:103063021-103063022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561565834 | chr8:103063029-103063030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375309145 | chr8:103063035-103063036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181732193 | chr8:103063077-103063078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544436811 | chr8:103063108-103063109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528667629 | chr8:103063123-103063124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116910820 | chr8:103063128-103063129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562721168 | chr8:103063166-103063167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114660168 | chr8:103063278-103063279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs57967936 | chr8:103063305-103063306 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs139576724 | chr8:103063332-103063333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569281079 | chr8:103063336-103063337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185162389 | chr8:103063344-103063345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189574044 | chr8:103063354-103063355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4434591 | chr8:103063450-103063451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567501289 | chr8:103063459-103063460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75597403 | chr8:103063466-103063467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553092099 | chr8:103063469-103063470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573769731 | chr8:103063470-103063471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543289810 | chr8:103063485-103063486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578157046 | chr8:103063492-103063493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs76490686 | chr8:103063577-103063578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557422139 | chr8:103063606-103063607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181304940 | chr8:103063609-103063610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543344733 | chr8:103063628-103063629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1984341 | chr8:103063643-103063644 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs528734230 | chr8:103063656-103063657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1573313 | chr8:103063665-103063666 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs5893599 | chr8:103063667-103063668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Cancer | 20164920 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 20409316 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21611746 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Prostate cancer | 22341455 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:103051600-103064600 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr8:103053800-103072600 | Weak transcription | Aorta | Aorta |
3 | chr8:103056600-103066000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:103057200-103064600 | Weak transcription | Right Atrium | heart |
5 | chr8:103057400-103067200 | Weak transcription | Fetal Heart | heart |
6 | chr8:103057400-103068600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr8:103057600-103068600 | Weak transcription | Left Ventricle | heart |
8 | chr8:103057600-103068800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
9 | chr8:103063200-103065800 | Enhancers | Ovary | ovary |
10 | chr8:103063200-103066600 | Enhancers | Fetal Brain Female | brain |
11 | chr8:103063400-103063600 | Enhancers | Psoas Muscle | Psoas |
12 | chr8:103063400-103064600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr8:103063600-103064000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr8:103063600-103066600 | Weak transcription | Psoas Muscle | Psoas |